First Time Customer? First Time Order? Get your 25% Off [Click Here]
 Regeneration & Aging Research, Immunology & Inflammatory Research

ARA-290

ARA-290 is a synthetic peptide consisting of a defined 11–amino-acid sequence. It is produced via peptide synthesis and supplied for use in controlled laboratory research environments.

Supplied as a lyophilized peptide powder, ARA-290 is intended exclusively for in-vitro laboratory research where high-purity peptide material is required.

In stock
Select Weight
Select Amount
1
$51.00Order more, save more

Add 1 more for 2% off.

Free Shipping on All Orders $175+

Product Usage: Not for Human or Veterinary UsePure Health Peptides products are supplied to qualified research professionals and institutional users for in vitro laboratory research only. KYC verification is required prior to order fulfillment, and we reserve the right to refuse orders that do not meet buyer qualification criteria. These products are not drugs, foods, cosmetics, diagnostic products, or dietary supplements, have not been evaluated by the FDA, and are not intended for human or animal use. Any such use is prohibited and may violate federal, state, or local law. By purchasing, the buyer represents and warrants that the product will be used solely for in vitro research. The buyer agrees to indemnify, defend, and hold harmless Pure Health Peptides, its officers, employees, and agents from and against any and all claims, damages, losses, liabilities, costs, and expenses (including reasonable attorneys fees) arising out of or relating to the buyer’s use, handling, storage, or disposition of the product in any manner inconsistent with its research-use-only designation or applicable law.

Description

Product Name:

ARA-290 (Cibinetide Peptide)

Chemical Information:
  • Molecular Formula: C₅₁H₈₄N₁₆O₂₁
  • Molecular Weight: ~1257.3 g/mol
  • Sequence: pGlu-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser
    (11-amino-acid erythropoietin Helix-B surface peptide)
Molecular Structure:



Molecular Structure

Product Description:

ARA-290 is a synthetic peptide consisting of a defined 11–amino-acid sequence. It is produced via peptide synthesis and supplied for use in controlled laboratory research environments.

Supplied as a lyophilized peptide powder, ARA-290 is intended exclusively for in-vitro laboratory research where high-purity peptide material is required.

Research Applications:

ARA-290 is studied in controlled laboratory settings for:

  • Characterization of peptide structural properties in vitro
  • Analysis of peptide stability and degradation profiles
  • Investigation of physicochemical properties of synthetic peptide sequences
  • Evaluation of peptide behavior under controlled laboratory conditions
  • Analytical profiling of peptide consistency and composition
Storage and Handling:
  • Store lyophilized powder at −20 °C
  • After reconstitution, maintain at 2–8 °C
  • Use promptly after reconstitution
  • Handle using standard aseptic laboratory technique
Product Specifications:
  • Purity: ≥99% (HPLC Certified)
  • Appearance: Lyophilized white to off-white powder
  • Solubility: Soluble in aqueous laboratory buffers; solubility varies with pH and medium
Compliance Notice:

ARA-290 is FOR RESEARCH USE ONLY. It is not intended for human or veterinary use. This product has not been evaluated by the FDA. Misuse of this product is strictly prohibited and may violate federal, state, or local laws. By purchasing this product, buyer represents and warrants that it will be used only for in vitro research purposes.

Certificate of Analysis

Certificate of Analysis

At Pure Health Peptides, transparency is key. Every batch is third-party tested in the USA, with Certificates of Analysis (COAs) readily available for verification, giving researchers confidence in their work.

View Certifications

Frequently Asked Questions

What is ARA-290?
ARA-290 is a synthetic 11-amino-acid peptide (sequence pyroGlu-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser) derived from the helix-B domain of erythropoietin (EPO). It has CAS number 1208243-50-8, molecular formula C51H84N16O21, and a molecular weight of approximately 1257.3 g/mol. Pure Health Peptides supplies it as a lyophilized powder strictly for in vitro laboratory research.
Why is ARA-290 also called cibinetide?
Cibinetide is the international non-proprietary name for the same 11-residue erythropoietin-derived peptide; ARA-290 is the development code used across much of the research literature. The two names refer to an identical compound.
What is ARA-290 studied for in research?
In controlled laboratory settings, ARA-290 is studied as a peptide that engages the innate repair receptor - a heteroreceptor complex of the EPO receptor and the CD131 beta-common subunit. Research literature reports that it corresponds only to the helix-B surface region and is characterized as selective for this heteroreceptor complex rather than the homodimeric EPO receptor. These are research findings; all applications are non-clinical.
What are ARA-290's chemical specifications, and what size does it come in?
ARA-290 has the molecular formula C51H84N16O21 and a molecular weight of approximately 1257.3 g/mol (refer to the lot-specific Certificate of Analysis for the exact value). It is supplied as a lyophilized white powder in 10 mg and 20 mg vials at greater than or equal to 99% purity (HPLC). Store in a cool, dry place away from light and moisture, and consult the Safety Data Sheet before handling.
Where can I buy ARA-290, and is it third-party tested?
ARA-290 is available from Pure Health Peptides as research-grade material in 10 mg and 20 mg vials at greater than or equal to 99% HPLC-verified purity. Every production lot is third-party tested in the US, with a lot-specific Certificate of Analysis available for verification.
Is ARA-290 intended for human or clinical use?
No. ARA-290 is for research use only and is not intended for human or veterinary use. It has not been evaluated by the FDA and is not a drug, food, cosmetic, or dietary supplement. It is supplied only to qualified research professionals for in vitro laboratory research, and KYC verification is required prior to fulfillment. Any use outside of controlled in vitro research is strictly prohibited.